This content is current only at the time of printing. This document was printed on 28 May 2022. A current copy is located at https://apvma.gov.au/node/922
You are here
In addition to the standard labelling requirements, labels for anti-inflammatories should also carry the information outlined below.
All products that contain phenylbutazone must include the following ‘Restraint’ statement. This should be placed immediately below the ‘Directions for use’ heading.
DO NOT USE in food-producing animals.
If a product is to be registered for use in horses, the following ‘Restraint’ statement should be included:
DO NOT USE in horses that may be used for human consumption.